These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 316700)

  • 21. Determinants of the anticoagulant effect of heparin in vitro.
    Bjornsson TD; Wolfram KM
    Ann N Y Acad Sci; 1981; 370():656-61. PubMed ID: 6168226
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin enhances the catalytic activity of des-ETW-thrombin.
    Goodwin CA; Deadman JJ; Le Bonniec BF; Elgendy S; Kakkar VV; Scully MF
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):77-83. PubMed ID: 8670135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The heparin-accelerated neutralisation of bovine alpha and beta thrombins by antithrombin III.
    MacGregor IR; Lane DA; Kakkar VV
    Biochim Biophys Acta; 1980 Sep; 632(1):131-7. PubMed ID: 7417517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of thrombin in plasma by heparin or arginine.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):146-53. PubMed ID: 17456623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombin III and heparin inactivation in thrombin involving reactions.
    Marciniak E
    Thromb Haemost; 1977 Aug; 38(2):486-93. PubMed ID: 579490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.
    Schapira M; Ramus MA; Waeber B; Brunner HR; Jallat S; Carvallo D; Roitsch C; Courtney M
    J Clin Invest; 1987 Aug; 80(2):582-5. PubMed ID: 3497179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interaction of heparin with human alpha-thrombin: effect on the hydrolysis of anilide tripeptide substrates.
    Griffith MJ; Kingdon HS; Lundblad RL
    Arch Biochem Biophys; 1979 Jul; 195(2):378-84. PubMed ID: 475396
    [No Abstract]   [Full Text] [Related]  

  • 28. Reduction of thrombus size in murine models of thrombosis following administration of recombinant α1-proteinase inhibitor mutant proteins.
    Sheffield WP; Eltringham-Smith LJ; Bhakta V; Gataiance S
    Thromb Haemost; 2012 May; 107(5):972-84. PubMed ID: 22370677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remarks on the interaction of thrombim and heparin.
    Arányi P; Batke J; Machovich R
    Arch Biochem Biophys; 1977 Jun; 181(2):678-9. PubMed ID: 900938
    [No Abstract]   [Full Text] [Related]  

  • 30. The transferable tail: fusion of the N-terminal acidic extension of heparin cofactor II to alpha1-proteinase inhibitor M358R specifically increases the rate of thrombin inhibition.
    Sutherland JS; Bhakta V; Filion ML; Sheffield WP
    Biochemistry; 2006 Sep; 45(38):11444-52. PubMed ID: 16981704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The catalysis by heparin of the reaction between thrombin and antithrombin.
    Evington JR; Feldman PA; Luscombe M; Holbrook JJ
    Biochim Biophys Acta; 1986 Mar; 870(1):92-101. PubMed ID: 3947650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-sensitive and nonsensitive forms of thrombin.
    Machovich R
    Biochim Biophys Acta; 1975 Jul; 400(1):62-8. PubMed ID: 1170899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
    Fuchs HE; Shifman MA; Pizzo SV
    Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin.
    Soslau G; Goldenberg SJ; Class R; Jameson B
    Platelets; 2004 May; 15(3):155-66. PubMed ID: 15203717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High affinity binding of thrombin to platelets. Inhibition by tetranitromethane and heparin.
    Workman EF; White GC; Lundblad RL
    Biochem Biophys Res Commun; 1977 Apr; 75(4):925-32. PubMed ID: 861034
    [No Abstract]   [Full Text] [Related]  

  • 38. Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.
    Haynes LM; Orfeo T; Mann KG; Everse SJ; Brummel-Ziedins KE
    Biophys J; 2017 Apr; 112(8):1634-1644. PubMed ID: 28445754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
    Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
    J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid, quantitative determination of clottable fibrinogen unaffected by heparin.
    Hershgold EJ; Martin B
    Am J Clin Pathol; 1975 Feb; 63(2):231-6. PubMed ID: 1115033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.